Lemonade officer sells 9,000 shares in 10b5-1 plan
Lemonade, Inc. reported that Chief Insurance Officer John Sheldon Peters sold common stock in a planned transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lemonade, Inc. reported that Chief Insurance Officer John Sheldon Peters sold common stock in a planned transaction. On January 22, 2026, he sold 9,000 shares of common stock at $90 per share in an open market sale coded as a disposition. The transaction was executed under a Rule 10b5-1 trading plan adopted on August 22, 2025, indicating it was pre-arranged rather than opportunistic.
Following this sale, Peters beneficially owns 70,228 shares of Lemonade common stock, held directly. The filing shows no derivative securities activity in this period.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | COMMON STOCK | 9,000 | $90.00 | $810K |
Footnotes (1)
- F1. Represents sale pursuant to a Rule 10b5-1 trading plan, adopted August 22, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Lemonade (LMND) disclose in this Form 4?
Was the Lemonade (LMND) insider sale part of a trading plan?
Does the Form 4 report any Lemonade (LMND) derivative securities for this insider?
What is the insider’s role at Lemonade (LMND)?
AI-generated analysis. How Rhea-AI works. Not financial advice.